Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It is intended to help adult smokers reduce nicotine withdrawal symptoms and cravings when attempting to quit smoking. The patch delivers a controlled amount of nicotine through the skin over several hours, providing a steady plasma concentration that mimics the level obtained from smoking, thereby easing the transition to a smoke‑free lifestyle.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicorette Invisipatch is a nicotine replacement therapy used in the management of tobacco dependence.

Smoking cessation: assists adult smokers in reducing withdrawal symptoms and cravings to support a quit attempt. Relapse prevention: provides a steady nicotine supply to help maintain abstinence after quitting. Tobacco dependence: serves as a non‑combustible nicotine source to replace cigarettes during cessation programs.

Common and rare adverse reactions have been reported with transdermal nicotine patches.

Common Side Effects: - Skin irritation at the application site - Sleep disturbance or vivid dreams - Nausea - Headache - Dizziness - Mild sweating

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, hives) - Tachycardia or hypertension - Chest pain - Severe contact dermatitis - Syncope (fainting) - Rare cases of arrhythmia

When using Nicorette Invisipatch, consider the following precautions.

Assess nicotine dependence level: determine appropriate patch strength under medical guidance. Avoid use in non‑smokers: nicotine exposure can cause adverse effects. Do not apply to damaged or irritated skin: may increase irritation. Monitor cardiovascular status: nicotine can affect heart rate and blood pressure. Pregnancy and breastfeeding: safety not established; consider alternatives. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Nicotine patches can interact with several medicines; review the following.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects of nicotine. - Beta‑blockers: nicotine may reduce their efficacy and cause tachycardia. - Insulin or oral hypoglycemics: nicotine can affect glucose control.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates (e.g., theophylline): nicotine may alter metabolism. - Antidepressants (SSRIs): monitor for increased side effects. - Alcohol: combined use may increase cardiovascular strain.